ANSHUMAN VERMA

About

I am a scientist, at L V Prasad Eye Institute, Hyderabad, India. Previously i worked as a scientist at MNR foundation for research and innovation, MNR medical college. I have ,
Twelve years of research experiences in vast area of biological field including molecular biology cellular biology, virology, stem cell and gene therapy.
Five years of working experiences in BSL2/3 lab with hands on training on advanced AAV vector production.
Ten years of experiences in ocular genetics with identifications of several disease-causing mutations using DNA sequencing techniques.
Eight publications in peer review journals and one book chapter.

Employment

• L V Prasad Eye Institute Scientist Faculty
  2023 - Present
• MNR Educational Trust Scientist
  2022 - 2023
• L V Prasad Eye Institute
  2021 - 2022
• UCSF Foundation Research associate
  2019 - 2020
• Narayana Nethralaya
  2015 - 2019

Education

• Aravind Eye Hospital Ph.D
  2008 - 2014

Projects & Funding

Projects & funding information is unavailable.

Publications (14)

• GAPO syndrome: a novel variant in ANTXR1 gene
  Ophthalmic Genetics 2024 DOI: 10.1080/13816810.2024.2345879
  +Save
• Band-shaped keratopathy in HNF4A-related Fanconi syndrome: a case report and review of the literature
  Ophthalmic Genetics 2023 DOI: 10.1080/13816810.2023.2285310
  +Save
• Correction to: identification and in silico analysis of a spectrum of SLC4A11 variations in indian familial and sporadic cases of congenital hereditary endothelial dystrophy (Orphanet Journal of Rare Diseases, (2022), 17, 1, (361), 10.1186/s13023-022-025…
  Orphanet Journal of Rare Diseases 2023 DOI: 10.1186/s13023-023-02791-6
  +Save
• Updates on congenital hereditary endothelial dystrophy
  Taiwan Journal of Ophthalmology 2023 DOI: 10.4103/tjo.TJO-D-23-00135
  +Save
• Commentary: Genomic testing is a powerful tool in diagnosing and managing anterior segment dysgenesis
  Indian Journal of Ophthalmology 2022 DOI: 10.4103/ijo.IJO_1022_22
  +Save
• Identification and in silico analysis of a spectrum of SLC4A11 variations in Indian familial and sporadic cases of congenital hereditary endothelial dystrophy
  Orphanet Journal of Rare Diseases 2022 DOI: 10.1186/s13023-022-02521-4
  +Save
• Identifications and in silico analysis of a spectrum of SLC4A11 mutations in Indian familial and non-familial cases of congenital hereditary endothelial dystrophy
  Research Square 2022 DOI: 10.21203/rs.3.rs-1623088/v1
  +Save
• New Frontier in the Management of Corneal Dystrophies: Basics, Development, and Challenges in Corneal Gene Therapy and Gene Editing
  Asia-Pacific Journal of Ophthalmology 2022 DOI: 10.1097/APO.0000000000000443
  +Save
• A Novel, Low-Cost, Wide-Field, Infant Retinal Camera, "Neo": Technical and Safety Report for the Use on Premature Infants.
  Translational vision science & technology 2019 DOI: 10.1167/tvst.8.2.2
  +Save
• Next generation sequencing identifies novel disease-associated BEST1 mutations in Bestrophinopathy patients.
  Scientific reports 2018 DOI: 10.1038/s41598-018-27951-8
  +Save